This inventor holds 1 USPTO granted patent. Top assignee: Sonus Pharmaceuticals, Inc.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Inventor Andrew M. Nienstedt: Innovating Therapeutics in Seattle
Introduction
Andrew M. Nienstedt, a dedicated inventor based in Seattle, WA, is recognized for his contributions to the field of therapeutics. With a keen focus on enhancing medical treatment options, he has secured a significant patent that reflects his innovative mindset and expertise within the pharmaceutical industry.
Latest Patents
Nienstedt holds one patent entitled "Compositions of tocol-soluble therapeutics." This invention aims to improve the efficacy of therapeutic compounds by enhancing their solubility, ultimately optimizing their delivery and effectiveness in medical applications.
Career Highlights
Currently, Andrew M. Nienstedt is employed at Sonus Pharmaceuticals, Inc., where he continues to advance his research into therapeutic solutions. His work not only contributes to the company's innovative goals but also positions him as a leader in developing effective therapeutic technologies.
Collaborations
Nienstedt collaborates with notable colleagues, including Panayiotis P. Constantinides and Karel J. Lambert. These partnerships highlight the collaborative spirit in the research community and underscore the importance of teamwork in advancing medical innovation.
Conclusion
Through his work, Andrew M. Nienstedt exemplifies the role of inventors in driving progress within the pharmaceutical industry. His patent on tocol-soluble therapeutics stands as a testament to his innovative thinking and commitment to improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile